Product Document Searching Made Easy by 2D Code! | TCI Materials Science News November 2025 | [TCIPracticalExample] Ullmann-type Coupling Reaction at Room Temperature... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 13614-98-7 | Product Number: M2288
Minocycline Hydrochloride
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 1G |
$144.00
|
15 | ≥60 | It can be shipped in about 2 weeks after ordering | |
| 5G |
$489.00
|
27 | ≥40 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | M2288 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__3H__2__7N__3O__7·HCl = 493.94 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 13614-98-7 |
| Related CAS RN
|
10118-90-8 |
| Reaxys Registry Number | 4836328 |
| PubChem Substance ID | 160871228 |
| Merck Index (14) | 6202 |
| MDL Number | MFCD00083669 |
Specifications
| Appearance | Light yellow to Yellow to Green powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 %(calcd.on anh.substance) |
| Specific rotation [a]20/D | -170 to -180 deg(C=0.5、0.1mol/L HCl) |
| Water | 4.3 to 8.0 % |
Properties (reference)
| Specific Rotation | -175° (C=0.5,0.1mL/L HCl) |
| Solubility in water | Slightly soluble |
| Solubility (soluble in) | Methanol, Dimethylformamide |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H360 : May damage fertility or the unborn child. H362 : May cause harm to breast-fed children. H317 : May cause an allergic skin reaction. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P263 : Avoid contact during pregnancy/ while nursing. P272 : Contaminated work clothing should not be allowed out of the workplace. P260 : Do not breathe dusts or mists. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P362 + P364 : Take off contaminated clothing and wash it before reuse. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | QI7630500 |
Transport Information:
| H.S.code* | 2941.30-000 |
Application
Gingipain inhibitor
Minocycline has been reported to inhibit gingipains, arginine-specific gingipains (HRgpA and RgpB), and lysine-specific gingipain (Kgp) from Porphyromonas gingivalis.1)
(The product is for research purpose only.)
(The product is for research purpose only.)
Reference
- 1) Inhibition of Trypsin-Like Cysteine Proteinases (Gingipains) from Porphyromonas gingivalis by Tetracycline and Its Analogues
- The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin
- Neuroprotective and anti-human immunodeficiency virus activity of minocycline
- Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
- Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
- A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
Application
Studies on Antibiotic Activity
References
Application
Neuroprotective Studies
References
PubMed Literature
Documents
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.